Biotronik announced the completion of enrollment in the BIOSOLVE-II trial — a clinical study investigating the safety and performance of DREAMS (DRug Eluting Absorbable Metal Scaffold).
Three out of five healthcare IT professionals believe that government mandates are having a negative effect on their industry, according to a study conducted by Peak 10, a national information technology (IT) infrastructure and cloud services provider. The majority (94 percent) also noted that complying with regulations influences IT strategy and decision-making. With rare exception, respondents claimed they lack the expertise necessary to navigate the maze of government regulations.
Drug-eluting balloons (DEBs) have been one of the long-awaited new transcatheter technologies to help reduce high restenosis rates in peripheral artery disease (PAD). The U.S. Food and Drug Administration (FDA) cleared C. R. Bard’s Lutonix 035 DEB in November 2014 and Medtronic’s In.Pact Admiral DEB in January 2015. Both are indicated for use in the superficial femoral and popliteal arteries in the upper leg.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
At the SPIE Medical Imaging Conference, ContextVision exhibited results from research conducted in collaboration with Texas Instruments and High Performance Consulting on 3-D adaptive filtering for improved image quality on portable medical devices. Björn Norell, research scientist at ContextVision, presented the findings.
Calgary Scientific Inc. announced the release of ResolutionMD 5.0, which offers better access to health information, supports increased teamwork and enhances communication among practitioners and patients.
Looking to “bypass the ordinary,” during last week’s episode titled: “The Bed's Too Big Without You,” the Grey’s Anatomy team at Seattle Grace Hospital was challenged with treating a radical tumor in the chest. After printing a 3-D model of the surgical area, Dr. Alex Karev commented that the best course of action to access the chest and successfully remove the mass would involve “the McGinn technique.”
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
iRhythm Technologies Inc. announced the study, “Cost Analysis and Clinical Outcomes of Ambulatory Care Monitoring in Medicare Patients,” was published in the Journal of Health Economics and Outcomes Research. The study assessed the costs incurred in the diagnosis, additional monitoring and following clinical events after the initial use of the Holter monitor among Medicare patients with arrhythmia.
Cerner Corp. and development partner Mortara Instrument have joined together to introduce CareAware Waveform Management. The system displays waveforms and other physiological data from patient monitoring systems and integrates them into the electronic health record (EHR).
Cardiac imaging accounts for about one-third of the source of X-ray radiation dose for all medical imaging. Expanding use of computed tomography (CT) for cardiac evaluations, use of nuclear imaging for myocardial perfusion exams and more complex transcatheter procedures in the cath lab have all increased patient exposure in recent years.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The spirit of collaboration to improve health with information technology came to Cleveland, Ohio, when the Integrating the Healthcare Enterprise (IHE) North American Connectathon 2015 opened in January 2015. Almost 100 organizations and 555 engineers attended this annual testing event.
Physicians who use the clinical reference tool, DynaMed from EBSCO Health, can now access the valuable, evidence-based content anywhere with the new DynaMedmobile app. The new app has been redesigned to make it easier and faster for physicians to find answers to clinical questions.
Transcatheter aortic valve replacement (TAVR) is not only a breakthough minimally invasive medical therapy, but offers a new business opportunity for hospitals that begin a program. The technology is viewed as cutting edge not only with clinicians, but also among the general public. This can be leveraged to promote the hospital as a cutting-edge facility and help attract new patients. However, creating these programs requires long-term financial, professional and equipment commitments, which may not be right for all hospitals. There are also concerns that a proliferation of TAVR centers may make programs less profitable and reduce the proficiency of any one center as patient volumes decrease if patients are spread between many competing hospitals.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Most “risk calculators” used by clinicians to gauge a patient’s chances of suffering a heart attack and guide treatment decisions appear to significantly overestimate the likelihood of a heart attack, according to results of a study by investigators at Johns Hopkins and other institutions.
Micell Technologies, Inc. announced the commercial availability of the MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES) in Europe. Stentys, Micell’s distribution partner in Paris, plans a controlled launch in Western Europe followed by a full commercial launch for the second half of 2015 in selected countries within Europe, Middle East, Southeast Asia and Latin America.
Certain types of chemotherapy are associated with heart issues known as cancer therapeutics-related cardiac dysfunction. However, symptoms don’t appear until the issue is already advanced and potentially deadly. Experts at Baylor College of Medicine say early screening and monitoring using echocardiograms could be the key to helping cancer survivors stay heart-healthy and get their life back.
February 19, 2015
